icon-account icon-glass
Free shipping on orders of $75 or more

Hari Om Hemp at CannMed 2019

Posted by Dustin Carr on

Hari Om Hemp at CannMed 2019
Hari Om Hemp at CannMed 2019 
In sunny Pasadena, California

Hari Om Hemp at CannMed 2019

Hari Om Hemp CEO Leigh Carr had the privilege of being able to attend the 2019 CannMed Conference in Pasadena, California in late September this year.  CannMed is a conference that helps bring together all those in the medical cannabis field to share new discoveries and ideas.  Leigh who holds a nursing background (BSN, RN) went and attended the CannMed Conference and got to learn from some of the biggest names in the cannabis industry.

Godfather of Cannabis medical research, Dr. Ralphael Mechoulam

First, if you are unfamiliar with him, here is a quick preview of Dr. Mechoulam discussing coming to CannMed 2019 to reveal some of his latest research.  

The Godfather of Cannabis medical research, Dr. Raphael Mechoulam attended the conference as the keynote speaker this year.  CEO and Hari Om Hemp co-founder Leigh Carr said “The second he walked onto the stage and everyone in the room stood up and applauded him I got chills and tears.  This is something I will talk about for years to come, getting to see him present for his very last time in the United States.  The grandfather of Cannabis research was in the same room as I and that is something that not many can say. What an honor it was to get to see him present his latest research on the acid form of cannabinoids in person.  From the beginning to the end, I had chills listening to him present. He was applauded at the end with a standing ovation as well.” 

At the conference, Dr. Mechoulam announced some of his latest breakthrough research on cannabinoid acids, as he had announced that he and his team had developed a process for creating synthetic, stable acids that are ready to be licensed for drug development and subsequent research.

Dr. Mechoulam was not the only cannabis rockstar in attendance, as was Zelda Therapeutics co-founder Mara Gordon.  

Zelda Therapeutics co-founder Mara Gordon with Leigh Hari Om Hemp

Mara was seen in the Windy Borman documentary ‘Mary Janes: Women of Weed’ as well as 'Weed The People'.  For Leigh, it was another star struck moment, “it took me 3 times passing her before I got up the courage to stop and talk with her. To meet someone whom I said I wanted to be after watching the movie 'Weed The People" is such an amazing honor.  This women right her is my role model and I want to be able to do what she is doing in the midwest and do it especially with children with special needs. Mara Gordon is a woman on a mission and her mission is the same as mine, to spread education on this powerful plant and get everyone the access that they need.”

A few other big names who Leigh got the pleasure to learn from and meet include Healer Founder Dr. Dustin Sulak.  As well as one of the premier authorities on Cannabis and its medical capabilities, Dr. Bonnie Goldstein who has published many well known works on Cannabis.

Hari Om Hemp Dr. Dustin Sulak

Leigh with Dr. Sulak

Hari Om Hemp Dr. Bonnie Goldstein

Leigh with Dr. Goldstein

Overall, when asked about the coolest and best part about the conference, Leigh responded by saying “being in rooms full of people with the same passion that I do about this plant and the amazing MEDICINAL benefits of it." 

She continued "Everyone knows the power of this plant and how it can help so many people and we all want to be able to break the stigma and be able to continue researching Cannabis and Cannabinoids as medicine. What an amazing place to be with so many passionate individuals.  Everyone there is awake and knows how corrupt our government is.  For doctors to tell me they cannot get their studies published because they do not want us knowing the proven scientific research is a disservice to all of our patients and medical professionals that are wanting to see this research so they can also recommend this plant to patients.”

 


Older Post Newer Post


0 comments


Leave a comment

Please note, comments must be approved before they are published